Radcliffe Capital Management
SBCWW icon

Radcliffe Capital Management’s SBC Medical Group Warrants SBCWW Stock Holding History

Radcliffe Capital Management’s Portfolio SBCWW Stock Details SBCWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-300,000
Closed -$14.2K – 255
2023
Q3 		$14.2K Hold
300,000
– – ﹤0.01% 304
2023
Q2 		$16.8K Hold
300,000
– – ﹤0.01% 356
2023
Q1 		$16.1K Hold
300,000
– – ﹤0.01% 457
2022
Q4 		$3.06M Buy
+300,000
New +$13.9K 0.1% 336

Other funds holding SBCWW

Mangrove Partners
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Shaolin Capital Management
Shaolin Capital Management Miami, Florida $2.42B AUM 0.61% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Schechter Investment Advisors
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AQR Arbitrage
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Taconic Capital Advisors
Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.52B AUM 24.83% 1-Year Est. Return
Periscope Capital
Periscope Capital Toronto, Ontario, Canada $990M AUM 4.73% 1-Year Est. Return

Radcliffe Capital Management's SBCWW Position: Q4 2023 in Review

Radcliffe Capital Management sold out of SBC Medical Group Warrants (SBCWW) in Q4 2023, closing a stake of 300,000 shares — an estimated $14.2K sold.

Radcliffe Capital Management first reported a position in SBCWW in Q4 2022 and held it in 4 quarters. The position peaked at $3.06M in Q4 2022. 31 funds tracked by Wall St. Rank hold SBCWW as of Q4 2023.

  • Radcliffe Capital Management reported no remaining SBC Medical Group Warrants position as of Q4 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 300,000 SBC Medical Group Warrants shares in Q4 2023, an estimated $14.2K.
  • Radcliffe Capital Management first reported a position in SBC Medical Group Warrants in Q4 2022 and held it in 4 quarters.
  • Radcliffe Capital Management's SBC Medical Group Warrants position peaked at $3.06M in Q4 2022.
  • 31 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q4 2023.

Based on Radcliffe Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.